Shigeki Kusamura

11PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Predictive and prognostic markersMolecular targetsEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 27, 2026
Tailoring HIPEC with Patient-Derived Organoids in Colorectal Peritoneal Metastases: Results from the First Stage of the Prospective Phase II OrganoHIPEC Clinical Trial (Clinicaltrials.gov NCT06057298).

|Aug 16, 2025
Multisocietal Consensus on the use of Cytoreductive Surgery and HIPEC for the Treatment of Pseudomyxoma Peritonei: A GRADE Approach for Evidence Evaluation and Recommendation.

Shigeki Kusamura, Edward Levine, Michela Cinquini

|Aug 08, 2025
Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Epithelial Ovarian Cancer: A GRADE Approach for Evidence Evaluation and Recommendation.

Donnal Brennan, Amy Hawarden, Michela Cinquini

|Apr 14, 2025
Clinical and Pathological Risk Factors for Peritoneal Metastases in a Surgical Series of T4 Colorectal Cancers.

Dario Baratti, Carlo Galdino Riva, Marcello Guaglio

|Dec 17, 2024
Multi-Society Guideline on Cytoreductive Surgery and HIPEC: Methodology and Overview of the Results.

Michela Cinquini, Shigeki Kusamura, Antonino Carmelo Tralongo

|Nov 29, 2024
Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Diffuse Malignant Peritoneal Mesothelioma: A GRADE Approach for Evidence Evaluation and Recommendation.

Shigeki Kusamura, Michela Cinquini, David Morris

Pageof 2

Frequent Collaborators

7 joint publications

Marcello Guaglio

5 joint publications

Michela Cinquini

3 joint publications

Andreas Brandl

2 joint publications

Manuela Robella